Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1842376

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1842376

Middle East Prefilled Syringes Market Size, Share & Trends Analysis Report By Type (Disposable, Reusable), By Material (Glass, Plastic), By Application, By Channel, By Country, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4250
Printable PDF & Excel (5-User License)
USD 5250
Printable PDF & Excel (Enterprise License)
USD 7250

Add to Cart

Middle East Prefilled Syringes Market Summary

The Middle East prefilled syringes market size was estimated at USD 126.4 million in 2024 and is projected to reach USD 253.4 million by 2033, growing at a CAGR of 8.10% from 2025 to 2033. The increase in chronic diseases in the Middle East region, such as cancer, and a growing focus on early disease diagnosis and chronic disease management, continue to increase demand for safer and more efficient drug delivery systems like prefilled syringes.

Furthermore, government initiatives to widen reimbursement coverage and access to healthcare have increased the prospects for mindful use of prefilled syringes in hospitals and across various sectors, especially in Gulf countries, which have successfully improved their healthcare infrastructure.

The Middle East has witnessed a notable increase in product entries and strategic expansions by leading pharmaceutical companies in recent months. For instance, in May 2025, Pfizer launched the region's first prefilled autoinjector therapy for hemophilia in the UAE, providing patients with a once-weekly, self-administered treatment that reduces hospital visits and improves convenience. This initiative aims to enhance access to advanced injectable therapies, but the key takeaway is the increasing use of patient-friendly drug delivery systems in the region.

The medical device markets in the region are the largest in the United Arab Emirates and Saudi Arabia. Ongoing disease burden, rising healthcare expenditures, and greater privatization in healthcare are some of the major drivers expected to boost the prefilled syringe industry throughout this forecast period.

The prevalence of chronic diseases in the Middle East is significant, primarily diabetes, and this increases the demand for prefilled syringes. Moreover, patients with diabetes often rely on prefilled syringes due to the convenience and easy usage associated with these products. One of the key benefits of these syringes is their enhanced dose accuracy, along with the decreased risk of contamination. As chronic disease continues to grow in this region, prefilled syringes will likely be more frequently adopted by both patients and healthcare providers, thus fueling market growth.

Along with this rising demand, the manufacturing companies in the Middle East are expanding local production and distribution of prefilled syringes. For instance, Al Shifa Medical Syringe Manufacturing Co. in Saudi Arabia produces prefilled syringes with sterile saline solutions, Julphar in the UAE offers a range of prefilled injectable therapies, and Fresenius Kabi provides its Simplist prefilled syringes across the region. These initiatives highlight the strategic efforts of manufacturers to meet growing healthcare needs and improve access to advanced drug delivery systems in the Middle East.

Middle East Prefilled Syringes Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the Middle East prefilled syringes market report based on product and application.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Disposable
  • Reusable
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Glass
  • Plastic
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Vaccines and Immunizations
  • Anaphylaxis
  • Rhumatoid Arthritis
  • Diabetes
  • Autoimmune Diseases
  • Onchology
  • Others
  • Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Mail order Pharmacies
  • Ambulatory Surgery Centers
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Oman
Product Code: GVR-4-68040-739-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Material
    • 1.2.3. Application
    • 1.2.4. Channel
    • 1.2.5. Regional
  • 1.3. Research Methodology
  • 1.4. Information analysis
    • 1.4.1. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Total Market: CAGR Calculation
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Material Outlook
    • 2.2.3. Application outlook
    • 2.2.4. Channel
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Middle East Prefilled Syringes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of chronic diseases
      • 3.2.1.2. Government initiatives and healthcare infrastructure development
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professionals
      • 3.2.2.2. Low awareness
  • 3.3. Prefilled Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Middle East Prefilled Syringes Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Prefilled Syringes Market: Type Movement Analysis
  • 4.3. Prefilled Syringes Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Disposable
    • 4.5.1. Disposable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Reusable
    • 4.6.1. Reusable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Middle East Prefilled Syringes: Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Prefilled Syringes Market: Material Movement Analysis
  • 5.3. Prefilled Syringes Market by Material Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Glass Syringes
    • 5.5.1. Glass Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Plastic Syringes
    • 5.6.1. Plastic Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Middle East Prefilled Syringes: Application Estimates & Trend Analysis

  • 6.1. Prefilled Syringes Market: Application Movement Analysis
  • 6.2. Prefilled Syringes Market by Application Outlook (USD Million)
  • 6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.4. Vaccines and Immunizations
    • 6.4.1. Vaccines and Immunizations Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Anaphylaxis
    • 6.5.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Rheumatoid Arthritis
    • 6.6.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Diabetes
    • 6.7.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Oncology
    • 6.9.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Middle East Prefilled Syringes: Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Prefilled Syringes Market: Channel Movement Analysis
  • 7.3. Prefilled Syringes Market by Channel Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Hospitals
    • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Mail Order Pharmacies
    • 7.6.1. Mail Order Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Ambulatory Surgery Centers
    • 7.7.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Middle East Prefilled Syringes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional Middle East Prefilled Syringes Market movement analysis
  • 8.3. Middle East Prefilled Syringes Market: Regional Estimates & Trend Analysis by Type, Material, Application, & Channel
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 8.4.1. Middle East
      • 8.4.1.1. Middle East Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 8.4.1.1.1. Qatar
          • 8.4.1.1.1.1. Key Country Dynamics
          • 8.4.1.1.1.2. Competitive Scenario
          • 8.4.1.1.1.3. Regulatory Framework
          • 8.4.1.1.1.4. Reimbursement scenario
          • 8.4.1.1.1.5. Qatar Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 8.4.1.1.2. Oman
          • 8.4.1.1.2.1. Key Country Dynamics
          • 8.4.1.1.2.2. Competitive Scenario
          • 8.4.1.1.2.3. Regulatory Framework
          • 8.4.1.1.2.4. Reimbursement scenario
          • 8.4.1.1.2.5. Oman Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 8.4.1.1.3. Saudi Arabia
          • 8.4.1.1.3.1. Key Country Dynamics
          • 8.4.1.1.3.2. Competitive Scenario
          • 8.4.1.1.3.3. Regulatory Framework
          • 8.4.1.1.3.4. Reimbursement scenario
          • 8.4.1.1.3.5. Saudi Arabia Prefilled Syringes Filler Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 8.4.1.1.4. UAE
          • 8.4.1.1.4.1. Key Country Dynamics
          • 8.4.1.1.4.2. Competitive Scenario
          • 8.4.1.1.4.3. Regulatory Framework
          • 8.4.1.1.4.4. Reimbursement scenario
          • 8.4.1.1.4.5. UAE Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 8.4.1.1.5. Kuwait
          • 8.4.1.1.5.1. Key Country Dynamics
          • 8.4.1.1.5.2. Competitive Scenario
          • 8.4.1.1.5.3. Regulatory Framework
          • 8.4.1.1.5.4. Reimbursement scenario
          • 8.4.1.1.5.5. Kuwait Prefilled Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. B.D
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Gerresheimer AG
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. SCHOTT Pharma AG
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Stevanto Group
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Nipro Corporation
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Terumo
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. West Pharmaceuticals
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Catalent
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Fresenius
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Aptar Pharma
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
Product Code: GVR-4-68040-739-9

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Middle East Prefilled Syringes Market, by Country, 2021 - 2033 (USD Million)
  • Table 4 Middle East Prefilled Syringes market, by Type, (USD Million) 2021-2033
  • Table 5 Middle East Prefilled Syringes market, by Material, (USD Million) 2021-2033
  • Table 6 Middle East Prefilled Syringes market, by application, (USD Million) 2021-2033
  • Table 7 Middle East Prefilled Syringes market, by Channel, (USD Million) 2021-2033
  • Table 8 Qatar Prefilled Syringes Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 Qatar Prefilled Syringes Market, By Material, 2021 - 2033 (USD Million)
  • Table 10 Qatar Prefilled Syringes Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 Qatar Prefilled Syringes Market, By Channel, 2021 - 2033 (USD Million)
  • Table 12 Oman Prefilled Syringes Market, By Type, 2021 - 2033 (USD Million)
  • Table 13 Oman Prefilled Syringes Market, By Material, 2021 - 2033 (USD Million)
  • Table 14 Oman Prefilled Syringes Market, By Application, 2021 - 2033 (USD Million)
  • Table 15 Oman Prefilled Syringes Market, By Channel, 2021 - 2033 (USD Million)
  • Table 16 Saudi Arabia Prefilled Syringes Market, By Type, 2021 - 2033 (USD Million)
  • Table 17 Saudi Arabia Prefilled Syringes Market, By Material, 2021 - 2033 (USD Million)
  • Table 18 Saudi Arabia Prefilled Syringes Market, By Application, 2021 - 2033 (USD Million)
  • Table 19 Saudi Arabia Prefilled Syringes Market, By Channel, 2021 - 2033 (USD Million)
  • Table 20 UAE Prefilled Syringes Market, By Type, 2021 - 2033 (USD Million)
  • Table 21 UAE Prefilled Syringes Market, By Material, 2021 - 2033 (USD Million)
  • Table 22 UAE Prefilled Syringes Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 UAE Prefilled Syringes Market, By Channel, 2021 - 2033 (USD Million)
  • Table 24 Kuwait Prefilled Syringes Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 Kuwait Prefilled Syringes Market, By Material, 2021 - 2033 (USD Million)
  • Table 26 Kuwait Prefilled Syringes Market, By Application, 2021 - 2033 (USD Million)
  • Table 27 Kuwait Prefilled Syringes Market, By Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Prefilled syringes market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Middle East prefilled syringes market, type outlook key takeaways (USD Million)
  • Fig. 12 Middle East prefilled syringes market: type movement analysis, 2024 & 2033 (USD Million)
  • Fig. 13 Disposable market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Reusable market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Middle East prefilled syringes market, material outlook key takeaways (USD Million)
  • Fig. 16 Middle East prefilled syringes market: material movement analysis, 2024 & 2033 (USD Million)
  • Fig. 17 Plastic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Glass market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Middle East prefilled syringes market, application outlook key takeaways (USD Million)
  • Fig. 20 Middle East prefilled syringes market: application movement analysis, 2024 & 2033 (USD Million)
  • Fig. 21 Vaccines and immunizations market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Anaphylaxis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Rheumatoid arthritis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Diabetes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Autoimmune diseases market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Oncology market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Middle East prefilled syringes market, end use outlook key takeaways (USD Million)
  • Fig. 29 Middle East prefilled syringes market: end use movement analysis, 2024 & 2033 (USD Million)
  • Fig. 30 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Mail order pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Middle East prefilled syringes market: Regional key takeaways (USD Million)
  • Fig. 34 Prefilled syringes market: regional outlook, 2024 & 2033 (USD Million)
  • Fig. 35 South Africa prefilled syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Saudi Arabia prefilled syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 UAE prefilled syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Oman prefilled syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Kuwait prefilled syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Kuwait prefilled syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 List of key emerging companies/technology disruptors/innovators
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!